ATE180974T1 - Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen - Google Patents

Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen

Info

Publication number
ATE180974T1
ATE180974T1 AT92909725T AT92909725T ATE180974T1 AT E180974 T1 ATE180974 T1 AT E180974T1 AT 92909725 T AT92909725 T AT 92909725T AT 92909725 T AT92909725 T AT 92909725T AT E180974 T1 ATE180974 T1 AT E180974T1
Authority
AT
Austria
Prior art keywords
small cell
compositions
methods
lung cancer
vasoactive intestinal
Prior art date
Application number
AT92909725T
Other languages
English (en)
Inventor
Terry W Moody
Original Assignee
Univ George Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ George Washington filed Critical Univ George Washington
Application granted granted Critical
Publication of ATE180974T1 publication Critical patent/ATE180974T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT92909725T 1991-03-29 1992-03-26 Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen ATE180974T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/676,987 US5273963A (en) 1991-03-29 1991-03-29 Compositions and methods for treating small cell and nonsmall cell lung cancers

Publications (1)

Publication Number Publication Date
ATE180974T1 true ATE180974T1 (de) 1999-06-15

Family

ID=24716841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92909725T ATE180974T1 (de) 1991-03-29 1992-03-26 Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen

Country Status (10)

Country Link
US (2) US5273963A (de)
EP (1) EP0578738B1 (de)
JP (1) JP3081643B2 (de)
AT (1) ATE180974T1 (de)
AU (1) AU653598B2 (de)
CA (1) CA2106978C (de)
DE (1) DE69229394T2 (de)
ES (1) ES2136084T3 (de)
SG (1) SG66274A1 (de)
WO (1) WO1992017199A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
TW224053B (de) * 1991-09-13 1994-05-21 Paul B Chretien
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5565424A (en) * 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
JP3853384B2 (ja) * 1994-09-09 2006-12-06 株式会社三菱化学ヤトロン 抗サイモシンα１モノクローナル抗体産生ハイブリドーマ
CA2232086A1 (en) * 1995-09-15 1997-04-03 Samir Chachoua Method for the identification and therapeutic use of disease-associated organisms, elements and forces
US6156725A (en) * 1996-08-16 2000-12-05 National Institute Of Immunology Drug for the treatment of cancer
US6492330B1 (en) 1996-08-16 2002-12-10 National Institute Of Immunology Antiangiogenic drugs
US5744363A (en) * 1996-08-16 1998-04-28 National Institute Of Immunology Method for establishing a tumor-cell line by preparing single-cell suspension of tumor cells from tumor biopsies
US6462017B1 (en) 2000-05-01 2002-10-08 Sciclone Pharmaceuticals, Inc. Method of reducing side effects of chemotherapy in cancer patients
EP1296704A4 (de) * 2000-06-14 2005-04-27 Chanda Bhuwalka Zaveri Peptide mit physiologischer aktivität
CN1665522A (zh) * 2002-06-28 2005-09-07 赛克隆制药公司 使用胸腺法新上调肿瘤抗原表达的方法
WO2004062684A2 (en) * 2003-01-16 2004-07-29 D. Collen Research Foundation Vzw Onderwijs En Navorsing Campus Gasthuisberg K.U. Leuven Treatment of thrombocytopenia with inhibitors of pacap
RU2372901C2 (ru) * 2007-04-24 2009-11-20 Государственное учреждение научно-исследовательский институт онкологии Томского Научного центра Сибирского отделения Российской академии медицинских наук (ГУ НИИ онкологии ТНЦ СО РАМН) Способ комбинированного лечения местнораспространенного немелкоклеточного рака легкого
RU2398525C1 (ru) * 2009-03-25 2010-09-10 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" Способ лечения рака легкого
RU2406452C1 (ru) * 2009-06-22 2010-12-20 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Росмедтехнологий" Способ лечения рака легкого
RU2414894C1 (ru) * 2009-06-29 2011-03-27 Учреждение Российской академии медицинских наук Российский онкологический научный центр имени Н.Н. Блохина РАМН Способ лечения рака легкого
RU2429842C1 (ru) * 2010-06-15 2011-09-27 Учреждение Российской академии медицинских наук Научно-исследовательский институт онкологии Сибирского отделения Российской академии медицинских наук (НИИ онкологии СО РАМН) Способ профилактики послеоперационных осложнений при комбинированном лечении больных немелкоклеточным раком легкого iii стадии

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4082737A (en) * 1977-02-22 1978-04-04 Hoffmann-La Roche Inc. Stabilized thymosin composition and method
DE3100974A1 (de) * 1980-01-18 1982-01-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente enthaltende arzneimittel mit immunregulierender wirkung, und thymosin(alpha)(pfeil abwaerts)1(pfeil abwaerts)-fragmente
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4560676A (en) * 1980-04-07 1985-12-24 The Rockefeller University N.sup.α -desacetylthymosinα1 and process
US5217953A (en) * 1990-11-30 1993-06-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Vasoactive intestinal peptide antagonist
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物

Also Published As

Publication number Publication date
CA2106978A1 (en) 1992-09-30
DE69229394T2 (de) 2000-01-05
AU653598B2 (en) 1994-10-06
CA2106978C (en) 2008-06-03
EP0578738B1 (de) 1999-06-09
WO1992017199A1 (en) 1992-10-15
US5273963A (en) 1993-12-28
EP0578738A1 (de) 1994-01-19
AU1694492A (en) 1992-11-02
ES2136084T3 (es) 1999-11-16
JP3081643B2 (ja) 2000-08-28
JPH06506225A (ja) 1994-07-14
DE69229394D1 (de) 1999-07-15
HK1012989A1 (en) 1999-08-13
US5721211A (en) 1998-02-24
SG66274A1 (en) 1999-07-20
EP0578738A4 (de) 1994-11-02

Similar Documents

Publication Publication Date Title
ATE180974T1 (de) Zusammensetzungen und methoden zur behandlung von kleinzell und nicht-kleinzell lungenkrebsen
ATE177475T1 (de) Monoklonale antikörper gegen c-kit
SE8900247L (sv) Ett nytt bifunktionellt tillvaextmodulerande glykoprotein
DE69738868D1 (de) Odieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
MX9700553A (es) Anticuerpos que activan un receptor de eritropoyetina.
TR199901971T2 (xx) Bir resept�re ba�lanan peptidler ve bile�ikler.
EP1746160A3 (de) Hepatozyt-Wachstumsfaktor-Rezeptor-Antagonisten und deren Anwendung
EP0552296A4 (en) Mouse monoclonal antibodies
ATE483733T1 (de) Hochaffine humane antikörper gegen tumorantigene
WO2001008636A8 (en) Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
DE69800716D1 (de) Neues verfahren zur herstellung von anti-humanen antigenrezeptoren und deren verwendungen
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
AU2003217055A1 (en) Protein for use in hypoxia related conditions
DE69129989D1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
ATE213507T1 (de) Methode zur bindung von material an das beta- amyloid-peptid
YU34196A (sh) Peptidi i jedinjenja koja se vezuju za receptor
ATE407698T1 (de) Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
ES8801729A1 (es) Un ensayo inmunometrio para proteina p21ras humana
DE68918217D1 (de) Familie von modifizierten Antikörpern mit hoher Affinität zur Behandlung von Krebs.
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
WO1999002545A3 (en) Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
TR199801027T2 (xx) Epitelyom te�his ve tedavisi i�in y�ntem.
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
IL187595A (en) Pharmaceutical preparation containing monoclonal antibody - tumors and production

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties